Apotea AB (publ) (STO:APOTEA)
Sweden
· Delayed Price · Currency is SEK 96.17
+1.53 (1.62%)
At close: Jun 4, 2025
Apotea AB Revenue
Apotea AB had revenue of 1.75B SEK in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 6.78B. In the year 2024, Apotea AB had annual revenue of 6.55B with 20.01% growth.
Revenue (ttm)
6.78B
Revenue Growth
+20.01%
P/S Ratio
1.45
Revenue / Employee
9.32M
Employees
800
Market Cap
9.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.55B | 1.09B | 20.01% |
| Dec 31, 2023 | 5.46B | 572.40M | 11.72% |
| Dec 31, 2022 | 4.88B | 303.30M | 6.62% |
| Dec 31, 2021 | 4.58B | 1.74B | 61.34% |
| Dec 1, 2019 | 2.84B | 746.02M | 35.65% |
| Dec 1, 2018 | Pro | Pro | Pro |
| Dec 1, 2017 | Pro | Pro | Pro |
| Dec 1, 2016 | Pro | Pro | Pro |
| Dec 1, 2015 | Pro | Pro | Pro |
| Dec 1, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Medicover AB | 23.56B |
| Camurus AB | 2.04B |
| Vimian Group AB | 4.24B |
| AddLife AB | 10.42B |